Table 1.
Characterization of CNVs for each cancer and control sets
| Tumor type | Samples | a Filtered samples (blood/adjacent) | CNVs | b CNVR (no) | CNV size (bp, mean) | c Median | Mean | SD |
|---|---|---|---|---|---|---|---|---|
| Breast (BRCA) | 555 | 336 (270/66) | 15836 | 9440 | 105943 | 46 | 47.1 | 14.2 |
| Brain (GBM) | 524 | 351 (344/7) | 18072 | 9286 | 111178 | 45 | 51.5 | 40.7 |
| Colon (COAD) | 444 | 342 (262/80) | 17830 | 9463 | 93777 | 49 | 52.1 | 17.1 |
| Kidney (KIRC) | 505 | 370 (51/319) | 17968 | 9574 | 99424 | 47 | 48.6 | 13.7 |
| Ovarian (OV) | 514 | 380 (314/66) | 19204 | 9777 | 95492 | 47 | 50.5 | 26.1 |
| Control (MIGEN) | 3074 | 2956 | 161910 | 79389 | 52 | 54.8 | 20.5 |
aFiltered samples are the number of cases after the exclusion of low-quality samples. The cases are categorized according to their source of normal tissues (blood or adjacent normal tissues). bCNVR are the number of CNVRs assessed in each of the five association studies with control (MIGEN). cThe median, mean and standard deviation (SD) of the number of CNVs per individual are shown.